Press Photos

Please note our terms of use governing the use of press images. By downloading images from our media database, you agree to these terms of use:
Press images may only be used for press purposes (print, electronic media, online) and may not be edited. Indicating the picture credits (source: Wacker Chemie AG) is obligatory. Images deleted from the media database may no longer be used in future. If a press image is used, please provide us with a copy or link. In other respects, the following copyright information shall apply: www.wacker.com/disclaimer

press pictures

Wacker Biotech Dr. Susanne Leonhartsberger

Dr. Susanne Leonhartsberger has been the managing director of Wacker Biotech GmbH since 2017, and, in her capacity as the head of the Biopharmaceuticals business line, is responsible for WACKER’s biologics business. “What especially motivates me is that we’re providing innovative medications for sick people all over the world – and that’s how most of us feel,” the biologist observes. (Photo: Wacker Chemie AG)

Order photo
press pictures

Wacker Biotech Amsterdam

Through its 2018 acquisition of SynCo Bio Partners B.V. in Amsterdam, the Netherlands, Wacker Chemie AG strengthened its pharmaceutical protein business and expanded its portfolio – an important step to keep pace with the rapidly growing biologics market. As a result, Wacker Biotech now has three sites: Jena, Halle and Amsterdam, with a total of about 330 employees. (Photo: Wacker Chemie AG)

Order photo
press pictures

Wacker Biotech Lab

Specialists in the field of microbial production: Wacker Biotech GmbH is a full-service contract manufacturer of biologics with more than 20 years of experience with microbial systems. The company’s core competencies include the manufacture of active pharmaceutical ingredients, vaccines and live bacteria. (Photo: Wacker Chemie AG)

Order photo
press pictures

Wacker Biotech Fermenter

Production at Wacker Biotech GmbH: the Munich-based WACKER Group entered the field of contract manufacturing for pharmaceutical proteins when it acquired Prothera GmbH and subsequently renamed it Wacker Biotech in 2005. (Photo: Wacker Chemie AG)

Order photo